These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9867120)

  • 1. Hepatitis C virus infection: pathogenesis, diagnosis and treatment.
    Pár A; Gervain J; Gógl A
    Scand J Gastroenterol Suppl; 1998; 228():107-14. PubMed ID: 9867120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of hepatitis C virus type and subtype distribution in Hungary].
    Gervain J
    Orv Hetil; 2018 May; 159(Suppl 2):2-8. PubMed ID: 29847988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of the type and subtype of the hepatitis C virus in chronic viral hepatitis patients in Hungary].
    Gervain J; Simon G; Papp I; Szabóné BK
    Orv Hetil; 2001 Jun; 142(25):1315-9. PubMed ID: 11488211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis, treatment, and follow-up of hepatitis C-virus related liver disease. Hungarian national consensus guideline].
    Hunyady B; Gervain J; Horváth G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I
    Orv Hetil; 2014 Mar; 155 Suppl():3-24. PubMed ID: 24631886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Structural analysis of the PKR-binding region of HCV 1b samples from patients with chronic hepatitis C and the correlation with IFN-sensitivity].
    Gervain J; Czibula A; Simon J; Kalmár T
    Orv Hetil; 2003 Jun; 144(24):1179-84. PubMed ID: 12866147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic viral hepatitis caused by B and C virus: diagnostic and therapeutic trends].
    Saracco G; Rizzetto M
    Recenti Prog Med; 1999 Nov; 90(11):595-600. PubMed ID: 10608149
    [No Abstract]   [Full Text] [Related]  

  • 7. [Standard diagnostic and therapeutic approach to chronic hepatitis C virus (HCV) infection 22 - guidelines].
    Urbánek P; Husa P; Plíšek S; RoŽnovský L
    Klin Mikrobiol Infekc Lek; 2017 Mar; 23(1):22-40. PubMed ID: 28467593
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis C therapy: Looking toward interferon-sparing regimens.
    Au TH; Destache CJ; Vivekanandan R
    J Am Pharm Assoc (2003); 2015; 55(2):e72-84; quiz e85-6. PubMed ID: 25658389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of HCV positive individuals with normal serum ALT levels.
    Van Thiel DH; Colantoni A; De Maria N
    Hepatogastroenterology; 1998; 45(20):321-4. PubMed ID: 9638399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus infection and immunomodulatory therapies.
    Forde KA; Reddy KR
    Clin Liver Dis; 2009 Aug; 13(3):391-401. PubMed ID: 19628156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of chronic hepatitis C].
    Rókusz L
    Orv Hetil; 2004 Aug; 145(32):1649-53. PubMed ID: 15384863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.
    De Mitri MS; Morsica G; Chen CH; Mele L; Baccarini P; Chianese R; Piccinini A; Lazzarin A; Pisi E
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):255-61. PubMed ID: 9646218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EASL Clinical Practice Guidelines: management of hepatitis C virus infection.
    European Association for the Study of the Liver
    J Hepatol; 2011 Aug; 55(2):245-64. PubMed ID: 21371579
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of interferon in the new era of hepatitis C treatments.
    Parekh PJ; Shiffman ML
    Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):649-56. PubMed ID: 24758387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenetic studies of the hepatitis C virus infection in an era of pan-genotype antiviral therapies - Effective treatment is coming.
    Ellwanger JH; Kaminski VL; Valverde-Villegas JM; Simon D; Lunge VR; Chies JAB
    Infect Genet Evol; 2018 Dec; 66():376-391. PubMed ID: 28811194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Status of Direct Acting Antiviral Agents against Hepatitis C Virus Infection in Pakistan.
    Khaliq S; Raza SM
    Medicina (Kaunas); 2018 Nov; 54(5):. PubMed ID: 30400604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis C virus infection--after 12 years. Advances in the management of chronic hepatitis C].
    Pár A
    Orv Hetil; 2002 Dec; 143(48):2667-74. PubMed ID: 12501575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon therapy in LKM-1 positive patients with chronic hepatitis C: follow-up by a quantitative radioligand assay for CYP2D6 antibody detection.
    Duclos-Vallée JC; Nishioka M; Hosomi N; Arima K; Leclercq A; Bach JF; Yamamoto AM
    J Hepatol; 1998 Jun; 28(6):965-70. PubMed ID: 9672171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular epidemiology of chronic hepatitis C (HCV) virus].
    Nitkiewicz J
    Przegl Epidemiol; 2004; 58(3):413-21. PubMed ID: 15730005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Predictive value of diverse viral factors in the response to treatment with interferon in patients with chronic hepatitis C].
    Giménez-Barcons M; Tajahuerce A; Sáiz JC
    Gastroenterol Hepatol; 1998 Oct; 21(8):404-12. PubMed ID: 9844281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.